Blockade of MCH1 receptor signalling ameliorates obesity and related hepatic steatosis in ovariectomized mice

British Journal of Pharmacology

Volumn 151, Issue 6, 2007, Pages 900-908

  Gomori, A ^a   Ishihara, A ^a   Ito, M ^a,a   Matsushita, H ^a   Mashiko, S ^a   Iwaasa, H ^a   Matsuda, M ^a   Bednarek, M A ^b   Qian, S ^b   MacNeil, D J ^b   Kanatani, A ^a  

^a BANYU PHARMACEUTICAL CO LTD   (Japan)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Liver; Melanin concentrating hormone; Obesity; Ovariectomy

Indexed keywords

HORMONE RECEPTOR; HORMONE RECEPTOR BLOCKING AGENT; MELANIN CONCENTRATING HORMONE RECEPTOR 1; MELANIN CONCENTRATING HORMONE RECEPTOR 1 ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; FATTY LIVER; FEMALE; GENE EXPRESSION; INTRAABDOMINAL FAT; LONG TERM CARE; MOUSE; NONHUMAN; OBESITY; OVARIECTOMY; PRIORITY JOURNAL; WEIGHT GAIN;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG DESIGN; FATTY LIVER; FEMALE; GENE EXPRESSION REGULATION; LIPOGENESIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; OBESITY; OVARIECTOMY; POSTMENOPAUSE; RANDOM ALLOCATION; RECEPTORS, SOMATOSTATIN; SIGNAL TRANSDUCTION; TRIGLYCERIDES; WEIGHT GAIN;

EID: 34447561729     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707292     Document Type: Article

References (51)

1. Abbott CR, Kennedy AR, Wren AM, Rossi M, Murphy KG, Seal LJ et al. (2003). Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormone. Endocrinology 144: 3943-3949.
2. Bednarek MA, Hreniuk DL, Tan C, Palyha OC, MacNeil DJ, Van Der Ploeg LH et al. (2002). Synthesis and biological evaluation in vitro of selective, high affinity peptide antagonists of human melanin-concentrating hormone action at human melanin-concentrating hormone receptor 1. Biochemistry 41: 6383-6390.
3. Blaustein JD (1992). Cytoplasmic estrogen receptors in rat brain: immunocytochemical evidence using three antibodies with distinct epitopes. Endocrinology 131: 1336-1342.
4. Chaffer CL, Morris MJ (2002). The feeding response to melanin-concentrating hormone is attenuated by antagonism of the NPY Y(1)-receptor in the rat. Endocrinology 143: 191-197.
5. Chen Y, Hu C, Hsu CK, Zhang Q, Bi C, Asnicar M et al. (2002). Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. Endocrinology 143: 2469-2477.
6. Folch J, Lees M, Sloane Stanley GH (1957). A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509.
7. Gomori A, Ishihara A, Ito M, Mashiko S, Matsushita H, Yumoto M et al. (2003). Chronic intracerebroventricular infusion of MCH causes obesity in mice. Melanin-concentrating hormone. Am J Physiol Endocrinol Metab 284: E583-E588.
8. Hanada R, Nakazato M, Matsukura S, Murakami N, Yoshimatsu H, Sakata T (2000). Differential regulation of melanin-concentrating hormone and orexin genes in the agouti-related protein/melanocortin-4 receptor system. Biochem Biophys Res Commun 268: 88-91.
9. Horton JD, Goldstein JL, Brown MS (2002). SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109: 1125-1131.
10. Ito M, Gomori A, Ishihara A, Oda Z, Mashiko S, Matsushita H et al. (2003). Characterization of MCH-mediated obesity in mice. Am J Physiol Endocrinol Metab 284: E940-E945.
11. Kawauchi H, Kawazoe I, Tsubokawa M, Kishida M, Baker BI (1983). Characterization of melanin-concentrating hormone in chum salmon pituitaries. Nature 305: 321-323.
12. Kela J, Salmi P, Rimondini-Giorgini R, Heilig M, Wahlestedt C (2003). Behavioural analysis of melanin-concentrating hormone in rats: evidence for orexigenic and anxiolytic properties. Regul Pept 114: 109-114.
13. Landau IT, Zucker I (1976). Estrogenic regulation of body weight in the female rat. Horm Behav 7: 29-39.
14. Ludwig DS, Mountjoy KG, Tatro JB, Gillette JA, Frenderich RC, Flier JS et al. (1998). Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus. Am J Physiol 274: E627-E633.
15. Ludwig DS, Tritos NA, Mastaitis JW, Kulkarni R, Kokkotou E, Elmquist J et al. (2001). Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J Clin Invest 107: 379-386.
16. Marsh DJ, Weingarth DT, Novi DE, Chen HY, Trumbauer ME, Chen AS et al. (2002). Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc Natl Acad Sci USA 99: 3240-3245.
17. Mashiko S, Ishihara A, Gomori A, Moriya R, Ito M, Iwaasa H et al. (2005). Antiobesity effect of a melanin-concentrating hormone 1 receptor antagonist in diet-induced obese mice. Endocrinology 146: 3080-3086.
18. Mcelroy JF, Wade GN (1987). Short- and long-term effects of ovariectomy on food intake, body weight, carcass composition, and brown adipose tissue in rats. Physiol Behav 39: 361-365.
19. Messina MM, Boersma G, Overton JM, Eckel LA (2006). Estradiol decreases the orexigenic effect of melanin-concentrating hormone in ovariectomized rats. Physiol Behav 88: 523-528.
20. Mickley KR, Dluzen DE (2004). Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice. Neuroendocrinology 79: 305-316.
21. Minami T, Oomura Y, Nabekura J, Fukuda A (1990). 17 Beta-estradiol depolarization of hypothalamic neurons is mediated by cyclic AMP. Brain Res 519: 301-307.
22. Mizuno TM, Kleopoulos SP, Bergen HT, Roberts JL, Priest CA, Mobbs CV (1998). Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and [corrected] in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 47: 294-297.
23. Moon YA, Shah NA, Mohapatra S, Warrington JA, Horton JD (2001). Identification of a mammalian long chain fatty acyl elongase regulated by sterol regulatory element-binding proteins. J Biol Chem 276: 45358-45366.
24. Mori T, Baba J, Ichimaru Y, Suzuki T (2000). Effects of rolipram, a selective inhibitor of phosphodiesterase 4, on hyperlocomotion induced by several abused drugs in mice. Jpn J Pharmacol 83: 113-118.
25. Murray JF, Baker BI, Levy A, Wilson CA (2000). The influence of gonadal steroids on pre-pro melanin-concentrating hormone mRNA in female rats. J Neuroendocrinol 12: 53-59.
26. Mystkowski P, Seeley RJ, Hahn TM, Baskin DG, Havel PJ, Matsumoto AM et al. (2000). Hypothalamic melanin-concentrating hormone and estrogen-induced weight loss. J Neurosci 20: 8637-8642.
27. Nahon JL (1994). The melanin-concentrating hormone: from the peptide to the gene. Crit Rev Neurobiol 8: 221-262.
28. Narita M, Mizuno K, Shibasaki M, Narita M, Suzuki T (2002). Upregulation of the G(q/11alpha) protein and protein kinase C during the development of sensitization to morphine-induced hyperlocomotion. Neuroscience 111: 127-132.
29. Nemoto Y, Saibara T, Ogawa Y, Zhang T, Xu N, Ono M et al. (2002). Tamoxifen-induced nonalcoholic steatohepatitis in breast cancer patients treated with adjuvant tamoxifen. Intern Med 41: 345-350.
30. Nemoto Y, Toda K, Ono M, Fujikawa-Adachi K, Saibara T, Onishi S et al. (2000). Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J Clin Invest 105: 1819-1825.
31. Nestler EJ, Carlezon Jr WA (2006). The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59: 1151-1159.
32. Niiya T, Osawa H, Onuma H, Suzuki Y, Taira M, Yamada K et al. (2001). Activation of mouse phosphodiesterase 3B gene promoter by adipocyte differentiation in 3T3-L1 cells. FEBS Lett 505: 136-140.
33. Ohtani H, Nomoto M, Douchi T (2001). Chronic estrogen treatment replaces striatal dopaminergic function in ovariectomized rats. Brain Res 900: 163-168.
34. Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ et al. (1996). A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380: 243-247.
35. Rossi M, Beak SA, Choi SJ, Small CJ, Morgan DG, Ghatei MA et al. (1999). Investigation of the feeding effects of melanin concentrating hormone on food intake - action independent of galanin and the melanocortin receptors. Brain Res 846: 164-170.
36. Rossi M, Choi SJ, O'shea D, Miyoshi T, Ghatei MA, Bloom SR (1997). Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology 138: 351-355.
37. Rovere C, Viale A, Nahon J, Kitabgi P (1996). Impaired processing of brain proneurotensin and promelanin-concentrating hormone in obese fat/fat mice. Endocrinology 137: 2954-2958.
38. Sailer AW, Sano H, Zeng Z, Mcdonald TP, Pan J, Pong SS et al. (2001). Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R. Proc Natl Acad Sci USA 98: 7564-7569.
39. Samuel VT, Liu ZX, Qu X, Elder BD, BilzI S, Befroy D et al. (2004). Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 279: 32345-32353.
40. Shearman LP, Camacho RE, Sloan SD, Zhou D, Bednarek MA, Hreniuk DL et al. (2003). Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats. Eur J Pharmacol 475: 37-47.
41. Shimada M, Tritos NA, Lowell BB, Flier JS, Maratos-Flier E (1998). Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396: 670-674.
42. Shimizu H, Ohtani K, Kato Y, Tanaka Y, Mori M (1996). Withdrawal of [corrected] estrogen increases hypothalamic neuropeptide Y (NPY) mRNA expression in ovariectomized obese rat. Neurosci Lett 204: 81-84.
43. Shimomura I, Bashmakov Y, Horton JD (1999). Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 274: 30028-30032.
44. Shimomura Y, Shimizu H, Takahashi M, Sato N, Uehara Y, Fukatsu A et al. (1990). The significance of decreased ambulatory activity during the generation by long-term observation of obesity in ovariectomized rats. Physiol Behav 47: 155-159.
45. Smith DG, Tzavara ET, Shaw J, Luecke S, Wade M, Davis R et al. (2005). Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice. J Neurosci 25: 914-922.
46. Tritos NA, Mastaitis JW, Kokkotou E, Maratos-Flier E (2001). Characterization of melanin concentrating hormone and preproorexin expression in the murine hypothalamus. Brain Res 895: 160-166.
47. Tritos NA, Vicent D, Gillette J, Ludwig DS, Flier ES, Maratos-Flier E (1998). Functional interactions between melanin-concentrating hormone, neuropeptide Y, and anorectic neuropeptides in the rat hypothalamus. Diabetes 47: 1687-1692.
48. Uno K, Katagiri H, Yamada T, Ishigaki Y, Ogihara T, Imai J et al. (2006). Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science 312: 1656-1659.
49. Wong GT (2002). Speed congenics: applications for transgenic and knock-out mouse strains. Neuropeptides 36: 230-236.
50. Yoshioka K, Yoshida T, Wakabayashi Y, Nishioka H, Kondo M (1988). Reduced brown adipose tissue thermogenesis of obese rats after ovariectomy. Endocrinol Jpn 35: 537-543.
51. Yu L, Liao PC (2000). Estrogen and progesterone distinctively modulate methamphetamine-induced dopamine and serotonin depletions in C57BL/6J mice. J Neural Transm 107: 1139-1147.